Ferdinand G.
CFO & Capital-Markets Strategist | SEC & Nasdaq Compliance Expert | Streamex • Alaunos Therapeutics • BioSig Technologies
- Role
- Interim Vice President of Finance Capital Strategy & Sec Reporting at Alaunos Therapeutics
- Location
- Palm Bay, FL, US
- LinkedIn followers
- 500 followers
About Ferdinand G.
Finance leader with 15 + years guiding high-growth, publicly traded and venture-backed…
Experience
Interim Vice President of Finance Capital Strategy & Sec Reporting
Feb 2024 — Present · Houston, TX, US
Quarterly & Annual Close Owner - Drove a faster, technology-enabled close by utilizing NetSuite—shortening timelines, improving data integrity, and supporting on-time SEC filings and smoother audits.SEC Filings Lead: Drafted and filed all Forms 10-Q, 10-K, 8-K, and S-3 amendments.Evaluated and re-papered March 2025 common-stock purchase warrants; positioned them for equity classification under ASC 480/815, averting a non-cash liability.Modeled anti-dilution scenarios, preserving 12 % shareholder value during follow-on financing.
Education
University of Johannesburg
Bachelors of Arts
2004 — 2006
University of South Africa/Universiteit van Suid-Afrika
Bachelor's degree
2010 — 2013
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.